ScholarIQanswers from OpenAlex

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma

PaperCitations, authors & open-access status

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma have?

ScholarIQcitation count

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma has 51 citations in the OpenAlex counts ScholarIQ stores.

When was NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma published?

ScholarIQyear

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma has 2006 year in the ScholarIQ index.

What is the open-access status of NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma?

ScholarIQoa status

NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma has closed oa status in the ScholarIQ index.

What is the DOI of NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma?

ScholarIQdoi

The DOI for NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma is on the source record.

What is the PMID of NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma?

ScholarIQpmid

The PMID for NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma is on the source record.

What is the OpenAlex record for NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma?

ScholarIQopenalex

The OpenAlex for NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial